Podcasts about cme

This episode is sponsored by Lightstone DIRECT. Lightstone DIRECT invites you to partner with a $12B AUM real estate institution as you grow your portfolio. Access the same single-asset multifamily and industrial deals Lightstone pursues with its own capital – Lightstone co-invests a minimum of 20% in each deal alongside individual investors like you. You're an institution. Time to invest like one.—-----------------------------What if planning wasn't about rigid to-do lists… but about carving out time for surfing with your kids, date nights, and saying “no” to overwhelm?In this practical episode, Dr. Bradley Block sits with Dr. Sarah Hart-Unger to explore her simple system for goal-setting and life management. Sarah reveals how she evolved from a time-strapped resident to a mom of three who balances medicine, podcasts, and adventure. Dive into yearly visioning (e.g., “What do I really want?”), quarterly goals, monthly calendars, and daily rituals that prevent fires from derailing your dreams. She shares pitfalls like neglecting partner time, the power of friend spreadsheets, and why spontaneity thrives on structure. Drawing from her book, “Best Laid Plans“ and courses, Sarah proves planning is the “knife-sharpening” for a delicious life—efficient, fun, and regret-free.If your to-do list runs you instead of the other way around, this is your blueprint to reclaim balance and build memories that matter.Three Actionable Takeaways:Start with yearly visioning: Dedicate hours annually to brainstorm big dreams (e.g., surfing with kids). List audacious goals, then revisit seasonally. Break into quarterly milestones like booking a trip, to keep them alive. This ensures daily life aligns with what excites you, turning “someday” into reality without overwhelm.Master task management: Use a “brain dump” to capture everything, then categorize into urgent vs. important. Schedule non-negotiables first (e.g., dates, friends), block deep work, and review weekly. Embrace tools like digital calendars or spreadsheets to track progress, preventing fires while creating space for spontaneity and joy.Evaluate opportunities thoughtfully: Before saying yes, scan your calendar for fit. Consider energy, family, and fun. Phases matter: Early career? Take more risks. With kids? Be selective. Prioritize relationships (e.g., friend tiers, date nights) to avoid regrets. Planning sharpens life like a chef's knife—efficient and delicious.About the Show:Succeed In Medicine  covers patient interactions, burnout, career growth, personal finance, and more. If you're tired of dull medical lectures, tune in for real-world lessons we should have learned in med school!About the Guest: Dr. Sarah Hart-Unger is a practicing physician, podcaster, and planning expert who honed her methods during residency and motherhood. Creator of Best Laid Plans Academy with over 100 graduates, she hosts the podcasts Best Laid Plans (solo on planning) and Best of Both Worlds (co-hosted with Laura Vanderkam on work-life fit). Her new book, Best Laid Plans: A Simple Planning System for Living a Life That You Love, offers modern tools for busy lives, balancing medicine, family, and fun.Connect with Dr. Sarah Hart-Unger:Book: Best Laid Plans (available mid-December at major retailers)Podcasts: Best Laid Plans; Best of Both WorldsWebsite: theshubox.com (for courses, blog, and more)About the Host:Dr. Bradley Block – Dr. Bradley Block is a board-certified otolaryngologist at ENT and Allergy Associates in Garden City, NY. He specializes in adult and pediatric ENT, with interests in sinusitis and obstructive sleep apnea. Dr. Block also hosts Succeed In Medicine podcast, focusing on personal and professional development for physiciansWant to be a guest?Email Brad at brad@physiciansguidetodoctoring.com  or visit www.physiciansguidetodoctoring.com to learn more!Socials:@physiciansguidetodoctoring on Facebook@physicianguidetodoctoring on YouTube@physiciansguide on Instagram and Twitter This medical podcast is your physician mentor to fill the gaps in your medical education. We cover physician soft skills, charting, interpersonal skills, doctor finance, doctor mental health, medical decisions, physician parenting, physician executive skills, navigating your doctor career, and medical professional development. This is critical CME for physicians, but without the credits (yet). A proud founding member of the Doctor Podcast Network!Visit www.physiciansguidetodoctoring.com to connect, dive deeper, and keep the conversation going. Let's grow! Disclaimer:This podcast is for informational purposes only and is not a substitute for professional medical, financial, or legal advice. Always consult a qualified professional for personalized guidance. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this episode of Bowel Sounds, hosts Dr. Amber Hildreth and Dr. Peter Lu talk to Dr. Tom Wallach, Assistant Professor of Pediatrics at SUNY Downstate, Chief of Pediatric Gastroenterology, Pediatric GI Fellowship director, and Research Director of Pediatrics. We talk about experience based research and how to implement these tools into medical education.Learning objectivesDefine experience based researchUnderstand how to incorporate experience based research into medical educationExplore the variety of tools available to scientists at all levels of training to conduct researchSupport the showThis episode may be eligible for CME credit! Once you have listened to the episode, click this link to claim your credit. Credit is available to NASPGHAN members (if you are not a member, you should probably sign up). And thank you to the NASPGHAN Professional Education Committee for their review!As always, the discussion, views, and recommendations in this podcast are the sole responsibility of the hosts and guests and are subject to change over time with advances in the field.Check out our merch website!Follow us on Bluesky, Twitter, Facebook and Instagram for all the latest news and upcoming episodes.Click here to support the show.

Your work world is built on endurance, intensity, and mastery. The culture is 'always on,' and you were trained to perform in conditions no one would call normal. The work is supranormal. It sits at the edge of reasonable and regularly exceeds what is sustainable by most standards. High performers like you often find themselves on an above-the-fray pedestal, expected to be tireless and self-sacrificing. Supranormal work can unlock extraordinary performance, but the cost adds up if it goes unchecked. In this episode, we look at where this culture came from, the cortisol spikes that shape your days, the hidden curriculum of self-sacrifice, and the countermeasures that keep you from burning out. It is a straight look at the supranormal experience and what it takes to do this work without losing yourself to it.Awake + Aware | Our 2026 RetreatJoin us at Awake and Aware, our 3-day retreat in Scottsdale, AZ. March 1-4, 2026. Space is limited.Learn More Here

When was Christ born? I held a livestream to tackle some of the most enduring mysteries surrounding the Christmas story, diving deep into scholarly debates concerning the timing of Christ's birth, the nature of the Star of Bethlehem, and the identity and traditions surrounding the Wise Men. The discussion also included a giveaway of a free copy of Sand Tanner’s book, Lighthouse, authored by Ronald Huggins. https://www.youtube.com/watch?v=3d0hOvJoXQc Don't miss our other conversations about Christmas: https://gospeltangents.com/lds_theology/christmas/ Copyright © 2025 Gospel Tangents All Rights Reserved The Great Dating Debate: When Was Christ Born? The discussion began by addressing the fact that the calendar we use today, created by the 6th-century monk Dionysius Exiguus. He mistakenly placed Christ's birth several years too late. There is no Year Zero. Modern scholars generally agree that Herod the Great died in 4 BC, a crucial historical marker, meaning Jesus could not have been born as late as 1 BC because Herod would have been dead for three or four years by then. Dr. Jeffrey Chadwick proposes that December of 5 BC is the correct birth month. However, Dr. Thomas Wayment argues that biblical writers like Matthew and Luke were composing gospels, not history, and were unconcerned with precise details, suggesting that historical data only allows us to know the date within a year or two, and certainly not within a specific month. Adding to the complexity is the mention of a census in Luke 2, which is historically problematic, as the census conducted by Quirinius (Cyrenius) is typically placed around 6 AD, about 10 years after Herod's death, creating a significant timeline contradiction. Explaining the Star of Bethlehem The question of what caused the Star of Bethlehem led to an examination of several astronomical and scientific theories, particularly in the context of both the Bible (Matthew 2) and the Book of Mormon (3rd Nephi 1). Information comes from several sources, including the 2004 documentary called Mystery of the Three Kings by Questar Entertainment. Planetary Alignment: Astronomer Michael Molnar proposed that the star was actually an occultation where the moon passed in front of Jupiter, a theory based on Babylon’s astrological beliefs concerning the birth dates of divine kings. Solar Eclipse: Another possibility, suggested by Jerry Grover, is a solar eclipse which occurred in 6 BC, a date near the proposed birth time. In Mesopotamia, eclipses were frequently associated with the rising of a new king or the death of an old king, which would explain why Herod was troubled. The eclipse was rare, rising in Mesoamerica and setting as a partial eclipse in Persia, where the Wise Men were thought to originate. Coronal Mass Ejection (CME): Grover also offered the idea of a CME (a massive ejection of plasma from the sun hitting Earth’s magnetosphere). This event could cause the northern lights (auroras) to become supercharged and move far south, appearing as “weird domes and other shapes in Mesoamerica”. This theory is particularly interesting because it could scientifically explain the Book of Mormon account that the night became “as light as day all night long” in the American Hemisphere, while the phenomenon might not have been noticed in the Middle East. Furthermore, the sign may have been accompanied by a crackling or hissing sound, as ions drop and release their charge in the atmosphere. Supernovas and comets are generally dismissed as options because they are either too short-lived or were historically seen as signs of impending doom. The Wise Men: Identity, Gifts, and Legacy The Wise Men (Magi or Magoi) were likely astrologers, healers, and dream readers from the east, specifically the Parthian/Persian Empire (modern Iran/Iraq area.) Their arrival in Jerusalem would have been concerning to Herod, especially since they were Persians entering Roman-controlled territory. The word Magoi is the same word used for magician or sorcerer. They may have been followers of the Zoroastrian religion, which is monotheistic and shares beliefs with Judaism, such as a belief in resurrection and a coming savior. Zoroastrian astronomers may have recognized the confluence of Jupiter and Saturn in 7 BC as a sign of a new king in Israel. The three traditional gifts carried profound meaning: Gold represented kingship. Frankincense represented divinity or God. Myrrh was extremely valuable (worth seven times the weight of gold) and represented healing; its use in embalming also served as a foreshadowing of Jesus's eventual death. The Magi are celebrated in many traditions, particularly in Spanish-speaking countries, where January 6th is known as Three Kings Day24,25. On this day, which occurs 12 days after Christmas, presents are exchanged, left by the Three Kings rather than Santa Claus. Legends regarding the Magi’s relics and tombs are found across the globe, including claims in Sava, Iran (recorded by Marco Polo); Axum, Ethiopia; Milan, Italy, and the most famous location in the West, the Cologne Cathedral in Germany. Don't miss our other conversations about Christmas: https://gospeltangents.com/lds_theology/christmas/ Copyright © 2025 Gospel Tangents All Rights Reserved

Alpha Warrior, Brad Zerbo, and Josh Reid return for another late-night After Hours session, diving into strange anomalies, missing data, and the growing conversation around solar activity and Earth's changing systems. The trio break down recent solar flares, CME activity, and irregularities in space-weather reporting, questioning why certain magnetosphere and seismic data appear delayed, altered, or quietly removed. They connect these patterns to historical solar cycles, pole-shift theories, volcanic and earthquake activity, and the broader implications for climate narratives and public preparedness. The discussion weaves through government transparency, scientific gatekeeping, and how information control shapes public perception of natural phenomena. With charts, speculation, humor, and classic After Hours tangents, Episode 9 explores whether the planet is entering a heightened phase of change, and why honest conversation about it remains so hard to find.

In episode 70 we discuss an article about prescription stimulant misuse. Han B, Jones CM, Volkow ND, et al.Prescription Stimulant Use, Misuse, and Use Disorder Among US Adults Aged 18 to 64 Years. JAMA Psychiatry. 2025;82(6):572–581. We also discuss the ASAM toolkit for addressing problems at the pharmacy with buprenorphine, and results of the 2024 NSDUH study. ASAM:Addressing Issues at the Pharmacy with Buprenorphine Prescriptions Link to report pharmacy issues STATNews:Tobacco use, binge drinking decrease as Americans consume more marijuana, survey finds --- This podcast offers category 1 and MATE-ACT CME credits through MI CARES and Michigan State University. To get credit for this episode and others, go tothis link to make your account, take a brief quiz, and claim your credit. To learn more about opportunities in addiction medicine, visitMI CARES. CME:https://micaresed.org/courses/podcast-addiction-medicine-journal-club/ --- Original theme music:composed and performed by Benjamin Kennedy Audio editing: Michael Bonanno Executive producer:Dr. Patrick Beeman A podcast fromArs Longa Media --- This is Addiction Medicine Journal Club with Dr. Sonya Del Tredici and Dr. John Keenan. We practice addiction medicine and primary care, and we believe that addiction is a disease that can be treated. This podcast reviews current articles to help you stay up to date with research that you can use in your addiction medicine practice. The best part of any journal club is the conversation. Send us your comments on social media or join our Facebook group. --- Email: addictionmedicinejournalclub@gmail.com Facebook:@AddictionMedJC Facebook Group:Addiction Medicine Journal Club Instagram:@AddictionMedJC Threads:@AddictionMedJC YouTube:addictionmedicinejournalclub Twitter/X:@AddictionMedJC --- Addiction Medicine Journal Club is intended for educational purposes only and should not be considered medical advice. The views expressed here are our own and do not necessarily reflect those of our employers or the authors of the articles we review. All patient information has been modified to protect their identities. Learn more about your ad choices. Visit megaphone.fm/adchoices

Mindsets to avoid burnout – Julie humanizes the patient and understands that whatever difficult things we are dealing with are temporary and have gratitudeWe must constantly recognize possible anchor bias and avoid cynicism to appropriately treat our patientsWe talk about our interactions with EMSBoth Julie and I remember working in EMS and the value that EMS brings in their report because they often see a lot of things we don't get from the history of the patientJulies advice for the new APP/ER doc - don't come to premature closure on a diagnosis, don't be afraid to ask questions, pay off your loans over buying the biggest house and latest toysWe talk about the baseline level of stress we deal with We talk about technological changes over time and imaging improvementsShe talks about the challenges that the Covid pandemic presented and the shortages of different things we have now encounteredJulie still finds meaning in finding the hard differential diagnosis and working towards positive patient interactions, the teamwork in the ERI talk about the importance of creating an approachable affect so everyone feels free to voice concernsGo look at the patient when the nurse is concerned Julie talks about the benefit for new EMT's and paramedics to reach out and ask for feedback and follow up on their patients, often we don't have time to pull them asideEMS doesn't have the best mechanisms in place for good feedback on every case like we do in the ER, where we see in real time how accurate our assessment may have been when the work up comes backSupport the showEverything you hear today from myself and my guests is opinion only and doesn't represent any organizations or companies that any of us are affiliated with. The stories you hear have been modified to protect patient privacy and any resemblance to real individuals is coincidental. This is for educational and entertainment purposes only and should not be taken as medical advice nor used to diagnose any medical or healthcare conditions. This is not medical advice. If you have personal health concerns, please seek professional care. Full show notes can be found here: Episodes - Practical EMS - Content for EMTs, PAs, ParamedicsMost efficient online EKG course here: Practical EKG Interpretation - Practical EMS earn 4 CME and learn the fundamentals through advanced EKG interpretation in under 4 hours. If you want to work on your nutrition, increase your energy, improve your physical and mental health, I highly recommend 1st Phorm. Check them out here so they know I sent you. 1st Phorm | The Foundation of High Performance Nutrition

Dr Manish A Shah from Weill Cornell Medicine in New York, New York, summarizes the treatment landscape and reviews relevant clinical datasets for patients with gastroesophageal cancers. CME information and select publications here.

Dr Manish A Shah from Weill Cornell Medicine in New York, New York, summarizes the treatment landscape and reviews relevant clinical datasets for patients with gastroesophageal cancers. CME information and select publications here.

Dr Gottfried E Konecny from the University of California, Los Angeles, summarizes the treatment landscape and reviews relevant clinical datasets for patients with ovarian cancer. CME information and select publications here.

Dr Manish A Shah from Weill Cornell Medicine in New York, New York, summarizes the treatment landscape and reviews relevant clinical datasets for patients with gastroesophageal cancers. CME information and select publications here.

Pošaljite nam SMS poruku.Anemija i transfuzija krvi i dalje se u svakodnevnoj kliničkoj praksi često posmatraju kao izolovani problemi i „nužna rješenja“. Međutim, savremeni dokazi jasno pokazuju da su i anemija i transfuzija povezane sa značajnim kratkoročnim i dugoročnim rizicima, uključujući poremećaje oksigenacije, imunološke i protrombotske učinke, infekcije, povećanu stopu komplikacija, mortalitet te nepovoljne onkološke ishode. Posebno je važno razumjeti da alogena pohranjena krv ne predstavlja adekvatnu zamjenu za pacijentovu vlastitu krv.Ovaj CME.ba tečaj fokusira se na ključno pitanje: koji rizik zapravo želimo izbjeći – anemiju, transfuziju ili oboje?Kroz jasno strukturiran i klinički orijentiran pristup, tečaj obrađuje patofiziologiju anemije, promjene koje nastaju u pohranjenim eritrocitima, kliničke posljedice transfuzije te koncept krvi kao „tekućeg organa“, čija se transplantacija ne bi trebala primjenjivati bez jasne indikacije i iscrpljenih alternativnih mjera.Centralni dio edukacije posvećen je Patient Blood Management (PBM) konceptu – interdisciplinarnom, dokazima utemeljenom programu usmjerenom na prevenciju i liječenje anemije, smanjenje krvarenja i racionalnu primjenu transfuzije. PBM se pokazao kao efikasan alat za poboljšanje kliničkih ishoda, smanjenje komplikacija i optimizaciju troškova, te se danas uspješno primjenjuje širom svijeta.----------Ukoliko želite postati partner portala CME.ba ili želite da se Vaš brand ili audio poruke pojave na našim podcastima, mollimo da se javite na email info@cme.ba. Više informacija za potencijalne partnere potražite na OVOM LINKU. Portal CME.ba je najbogatija platforma za medicinsko usavršavanje u regionu. Sve komentare ili prijedloge možete poslati na: Facebook Instagram Twitter LinkedIn Email na info@cme.ba Hvala na slušanju!

David Morgan is the publisher and CEO of The Morgan Report, a world-class publication designed to build and secure wealth. He talks rising prices in silver, gold, devaluation of the dollar, how they could tokenize land to back debt, CBDC, AI bubble, CME glitch, and much more. PLEASE SUBSCRIBE LIKE AND SHARE THIS PODCAST!!!    Watch Show Rumble- https://rumble.com/v72y4dc-ubi-cashless-life-and-the-boiling-frog-david-morgan.html YouTube- https://youtu.be/zgp3SME5Z0k   Follow Me X- https://x.com/CoffeeandaMike IG- https://www.instagram.com/coffeeandamike/ Facebook- https://www.facebook.com/CoffeeandaMike/ YouTube- https://www.youtube.com/@Coffeeandamike Rumble- https://rumble.com/search/all?q=coffee%20and%20a%20mike Substack- https://coffeeandamike.substack.com/ Apple Podcasts- https://podcasts.apple.com/us/podcast/coffee-and-a-mike/id1436799008 Gab- https://gab.com/CoffeeandaMike Locals- https://coffeeandamike.locals.com/ Website- www.coffeeandamike.com Email- info@coffeeandamike.com   Support My Work Venmo- https://www.venmo.com/u/coffeeandamike Paypal- https://www.paypal.com/biz/profile/Coffeeandamike Substack- https://coffeeandamike.substack.com/ Patreon- http://patreon.com/coffeeandamike Locals- https://coffeeandamike.locals.com/ Cash App- https://cash.app/$coffeeandamike Buy Me a Coffee- https://buymeacoffee.com/coffeeandamike Bitcoin- coffeeandamike@strike.me   Mail Check or Money Order- Coffee and a Mike LLC P.O. Box 25383 Scottsdale, AZ 85255-9998   Follow David X- https://x.com/silverguru22 Blog- https://www.themorganreport.com/blog/ Website-  https://www.themorganreport.com/   Sponsors Vaulted/Precious Metals- https://vaulted.blbvux.net/coffeeandamike McAlvany Precious Metals- https://mcalvany.com/coffeeandamike/ Independence Ark Natural Farming- https://www.independenceark.com/  

Dean's Chat hosts, Drs. Jensen and Richey, welcome Dr. Devon Glazer to the Podcast! This episode is sponsored by the American Podiatric Medical Association (APMA)! Dr. Devon Glazer, DPM, from Los Angeles, is a board-certified podiatric physician specializing in the medical and surgical care of foot and ankle disorders. Known for his strong fellowship program, his patient-centered approach and contemporary use of evidence-based medicine, Dr. Glazer combines precision, compassion, and innovation to help patients regain mobility and improve quality of life. Dr. Glazer completed his doctoral training in podiatric medicine followed by rigorous clinical residency training in foot and ankle surgery. He trained on the East Coast and this benefited his transition to Califonia! His clinical interests include sports injuries, trauma, reconstructive foot and ankle surgery, diabetic limb preservation, and complex forefoot and rearfoot pathology. He is recognized for his ability to translate advanced surgical techniques into practical, real-world outcomes for patients of all ages. Beyond clinical practice, Dr. Glazer is deeply committed to education, as he is the Scientific Director of "The Western", a prominant Podiatric Medical Symposium! , mentorship, and the advancement of the podiatric profession. He regularly contributes to professional development through teaching, public education, and collaborative work with peers across multidisciplinary healthcare teams. On this channel, Dr. Glazer shares: • Expert insights on foot & ankle health • Fellowship surgical education • Innovations in podiatric medicine • CME in Podiatry Whether you are a patient, student, or healthcare professional, Dr. Glazer's content is designed to educate, empower, and elevate the standard of foot and ankle care. Enjoy!

Dr Kerry A Rogers from The Ohio State University in Columbus summarizes the treatment landscape and reviews relevant clinical datasets for patients with chronic lymphocytic leukemia. CME information and select publications here.

Holiday demand reminded the markets who's in charge — beef hit rare production levels while premium cuts held firm. As poultry and grains wait it out, pork stays a value and dairy keeps sliding into bargain territory. With the calendar about to flip, the real question is what holds… and what finally gives in the new year.BEEF: Holiday demand pushed production to a rare 600K head, but premium cuts are still commanding top dollar. The big question now – have middle meats finally hit their seasonal ceiling, and what happens next when the calendar flips?POULTRY: Chicken pricing stays calm and steady as we head toward the new year. But with avian flu cases climbing again, could this quiet market be one headline away from changing fast?GRAINS: Corn, soy, and wheat continue to tread water, moving just enough to stay interesting. Until something breaks the pattern, this market looks content to wait it out.PORK: Bellies bounced back this week, but the pork market feels stuck in neutral. With plenty of value still reminding buyers why pork stays on the menu, does this calm stretch continue into January?DAIRY: Cheese keeps sliding while butter barely blinks, turning dairy into one of the best bargains on the board. The question now – how much lower can it really go before demand steps in?Savalfoods.com | Find us on Social Media: Instagram, Facebook, YouTube, Twitter, LinkedIn

In this week's Live from the Vault, Andrew Maguire explores how rising physical demand and institutional buying are pushing silver through key inflection points, challenging mispriced Western benchmarks and shaping a new pricing landscape.The London wholesaler comments on how BRICS-backed channels and short-squeeze dynamics are influencing global bullion flows, with physical demand from major institutions supporting prices as markets head into 2026.Send your questions to Andy here: https://www.speakpipe.com/LFTVTimestamps:00:00  Start02:34  Gold and silver surge as pricing shifts10:06  BRICS gold currency quietly returns18:01  BRICS gold-backed unit redefines global markets26:02  CME circuit breakers expose price control erosion34:06  China delivery pressure breaks silver shorts42:07  Institutional gold demand overwhelms market capsSign up for Kinesis on desktop:https://kinesis.money/kinesis-precious-metals/?utm_source=youtube&utm_medium=video&utm_campaign=lftv_253Download the Kinesis Mobile app - available App Store and Google Play:Apple: https://kms.kinesis.money/signupGoogle: https://play.google.com/store/apps/details?id=com.kinesis.kinesisappAlso, don't forget to check out our social channels where you can stay up to date with all the latest news and developments from the team.X: https://twitter.com/KinesisMonetaryFacebook: https://www.facebook.com/kinesismoney/Instagram: https://www.instagram.com/kinesismoney/Telegram: https://t.me/kinesismoneyTikTok: https://www.tiktok.com/@kinesismoneyThe opinions expressed in this video by Andrew Maguire and any guest are solely their own and do not reflect the official policy, position, or views of Kinesis. The information provided is for general informational purposes only and does not constitute investment advice, financial advice, or any other type of professional advice.Viewers are encouraged to seek independent financial advice tailored to their individual circumstances before making any decisions related to the gold market or other investments. Kinesis does not accept any responsibility or liability for actions taken based on the content of this video.

Dr Justin F Gainor, Dr Corey J Langer and Dr Misty Dawn Shields summarize the treatment landscape and review relevant clinical datasets for patients with lung cancer.CME information and select publications here.

Dr. Rob Bradsher is the Medical Director for the TeamHealth Hospitalist program at Baptist Memphis. He is from Arkansas and went to medical school at UAMS where he was inducted into Alpha Omega Alpha. He has practiced in Memphis as a hospitalist since 2014 after completing his residency training in the Osler program at Johns Hopkins Hospital. He has built a distinguished career in both academic medicine and clinical practice, serving as Program Director for a large Internal Medicine residency at the University of Tennessee Health Science Center for many years before transitioning into hospital leadership. Dr. Bradsher has been recognized with numerous teaching and leadership awards, including UTHSC's inaugural Program Director of the Year. Beyond healthcare, Dr. Bradsher is an unabashed family man, married to Allison and a proud father of 4 kids. He serves on the Board of Directors of the kids' school, Westminster Academy. He also loves tennis - as an avid recreational player, "tennis dad", and a big fan of the professional tours.With more than two decades in nursing and 16 years in leadership, Jodi Woods, MSN, RN, has dedicated her career to shaping both patient care and the growth of future leaders. Currently serving as Associate Chief Nursing Officer, she has spent 13 years at Baptist Memorial Hospital in Memphis in roles of Manager and Director, where she led teams with a focus on collaboration, innovation, and accountability. Passionate about ensuring positive patient experiences and high-quality care, Jodi thrives on mentoring and empowering others to achieve their professional goals while driving excellence in healthcare delivery.Dr. Nirmit Kothari presently serving as Associate Chief Medical Officer at Baptist Memorial Hospital, Memphis, TN. Dr. Kothari is a seasoned internist and hospital medicine specialist affiliated with Baptist Memorial Hospital–Memphis, with over two decades of medical experience.Link to claim CME credit: https://www.surveymonkey.com/r/3DXCFW3CME credit is available for up to 3 years after the stated release dateContact CEOD@bmhcc.org if you have any questions about claiming credit.

“Delivering a baby one day and holding a patient's hand at the end of life literally the next day...that continuity is very powerful,” says Dr. Jen Brull, board chair of the American Academy of Family Physicians (AAFP). And as she points out, that continuity also builds trust with patients, an increasingly valuable commodity when faith in medicine and science is declining. As you might expect given her role, Dr. Brull believes strengthening family medicine is the key to improving health and healthcare. Exactly how to do that is at the heart of her conversation with host Lindsey Smith on this episode of Raise the Line, which covers ideas for payment reform, reducing administrative burdens, and stronger support for physician well-being. And with a projected shortage of nearly forty thousand primary care physicians, Dr. Brull also shares details on AAFP's “Be There First” initiative which is designed to attract service-minded medical students – whom she describes as family physicians at heart -- early in their educational journey. “I have great hope that increasing the number of these service-first medical students will fill part of this gap.”Tune-in for an informative look at a cornerstone of the healthcare system and what it means to communities of all sizes throughout the nation.  Mentioned in this episode:AAFP If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

Drs. Priya Vakharia and Sarwar Zahid join host Dr. Jay Sridhar to discuss the history, major recent changes, and future of the Good Days Chronic Disease Fund as it pertains to medical management of patients with retinal disease. For all episodes or to claim CME credit for selected episodes, visit www.aao.org/podcasts.

Featuring perspectives from Dr Jeremy S Abramson and Dr Loretta J Nastoupil, including the following topics: Overview of Chimeric Antigen Receptor (CAR) T-Cell Therapy (0:00) Potential Treatment Benefits of CAR T-Cell Therapy (13:31) Cytokine Release Syndrome and Immune Effector Cell-Associated Neurotoxicity Syndrome (28:13) Finding Information About CAR T-Cell Therapy; Clinical Trials (36:28) Financial Issues; Risk of Infection (42:02) Coping with Anxiety; Healing and Moving On (53:27) CME information and select publications

Dr Jeremy S Abramson from Massachusetts General Hospital in Boston and Dr Loretta J Nastoupil from CommonSpirit Mercy Hospital in Durango, Colorado, discuss the clinical applications of chimeric antigen receptor T-cell therapy for patients with non-Hodgkin lymphoma. CME information and select publications here.

There's milk everywhere: more milk in the U.S., Europe and New Zealand than a year ago, soft Class IV, and Class III futures that could slip into the $13s once you plug in today's spot cheese and whey. With a long milk wave crashing over the dairy industry, will farmers start culling cows and leaving stalls empty? Inside the episode, the team churns through: Why strong balance sheets, paid-down debt and high cow values could delay a production pullback How lower feed costs shift the breakeven – but can't fully offset falling milk checks Why Western and cheese-focused regions like the Pacific Northwest, California and Idaho may struggle first How WPC 80, WPI and clear whey proteins have become the lone bulls – and why capacity constraints limit the industry's response Why there are limits to what customers can pay for whey, and where substitution is already happening It's a barn full of bears on butter, cheese and fluid milk, but the protein complex is still flexing. The question is how long that can last? Tune in to The Milk Check episode 88: One bull in a barn full of bears to hear how our traders are navigating a market that's bearish on volume but still bullish on protein. Got questions? We'd love to hear them. Submit below, and we might answer it on the show. Ask The Milk Check Ted Jacoby III: Welcome, everybody, to The Milk Check. It is December 5th. We’re gonna talk about markets today. And rather than boring you and having the same conversation we had three weeks ago, everything is still bearish. There’s milk everywhere. There’s milk all over the U.S. There’s milk all over Europe. There’s milk all over New Zealand. There’s a whole bunch more milk this year than last year. Things are long. It’s very likely things are gonna get longer before they get shorter. Today we have some of our usual suspects. My brother Gus has joined us today. We’ve got Josh White, we’ve got Joe Maixner, we’ve got Diego Carvallo. And, of course, myself. Looking forward to a great conversation. So, rather than discussing how bearish we can be on these markets, my question, and I’m gonna start by throwing this question at my brother, Gus, is Gus, how long do you think it’s gonna take for dairy farmers to start culling cows and for this milk [00:01:00] production to slow down? Gus Jacoby: I feel like milk price and farm economics are completely contingent on that and how bad those farm economics get with respect to the milk price. Class III is still relatively high. Obviously, Class IV is pretty poor right now. The way I see it, dairymen, at this moment in time, still have fairly strong balance sheets. So, the recent low prices haven’t affected ’em all that much. So, I don’t expect their behavior with respect to culling and whatnot to change. But I think in five, six months from now, assuming that the milk price is at or lower, and quite frankly, I think Class III probably does need to get a bit lower, you’ll start to see some of that behavior change. If I had to guess, either as early as early summer, but as late as maybe mid-fall, if farm economics don’t change, we’ll start to see dairymen begin to leave stalls open. I mean, they’re gonna cull a cow, collect that beef revenue that they can grab, and not necessarily buy the expensive heifer. Ted Jacoby III: You’re thinking it’s gonna take about six months for dairy farmers [00:02:00] to get to the point where they feel like they need to increase the amount of cows they’re selling in order to meet their cashflow needs? Gus Jacoby: That’s my best guess. And again, that can be either expedited or slowed down depending on where the milk price goes. Ted Jacoby III: Corn prices have really come down this year. Do you think the lower feed prices have lowered where that break even point is, or how low we need to go in milk price in order to really send those signals in a strong way? Gus Jacoby: Certainly, feed prices being lower are gonna be helpful to the farm economic model. This becomes a milk price discussion. If the cheese price continues to have that downward pressure and gets low enough, those feed prices won’t be low enough. It’s always related to their inputs. And certainly, cheap feed helps their cause to extend growth in the milk production model. Ted Jacoby III: Right now, on December 5th, the Class III prices for the first quarter are right around, let’s call it $15.50, but if you use today’s cheese price on the spot market at the CME in today’s whey price, you’re probably looking at something closer to $14, 14 and a quarter. [00:03:00] Is that low enough or do we need to go lower? Gus Jacoby: It’s low enough. But not low to expedite anything. Maybe that takes us into the late summer, and remember, it depends on where we’re talking here in the country. Milk production costs are different depending on where you exist in the country. And also payouts are a lot different in a lot of places, depending on where you exist in the country. So, some regions might struggle sooner than later. Ted Jacoby III: Which regions do you think are gonna struggle first? Gus Jacoby: The West, Pacific Northwest, I think California, areas like Idaho that are strongly cheese based. If you’re paying on a Class III price and it stabilizes, which I don’t anticipate here, then perhaps some of those regions might hold on longer. My guess is predicated on the forecast of Class III going a bit lower. Ted Jacoby III: I guess I’d have to agree with that ’cause I don’t think $14 a hundredweight is enough. Because we’re still in front of Christmas, and I think the market’s probably gonna get worse before it gets better. My hunch is we’re gonna see $13 milk this year. We’re gonna see it in Class IV, and we may be already [00:04:00] seeing it in Class IV as soon as December. I think we’re gonna see a 13 handle in Class III, probably most of the first quarter. Gus Jacoby: If you’ve got a Class III at 13, and Class IV holds as low as it is, which I would expect certainly in the first half of the year, and then you have your standard freight and other deducts in those milk checks, dairymen are now getting to an area that is very adverse. Ted Jacoby III: Even though we’re talking about really low prices, I think there’s a lot of dairy farmers out there that are in a pretty healthy place. Gus Jacoby: I would agree. Ted Jacoby III: They’re healthy in two ways. One, I think that many of them have been able to take the last two years and really pay down their debt. And so, they’re in a really good spot financially, just on the balance sheet alone. But the second thing is those cows, they’re worth twice what they were worth three years ago. And so, not only have they paid down their debt, but if they need to borrow more, they’ve got more collateral to borrow against because those cows are usually the collateral for the banks when the banks lend dairy farmers money. It’s [00:05:00] usually the cows and the land. My hunch is that this may go on longer than we expect because of how healthy dairy farmers are financially today. Not saying they’ll be healthy in four or five months, but they’re healthy today. And because of how much bankers are probably willing to lend them based on those balance sheets. Gus Jacoby: I agree that the balance sheets are strong at the moment, even after a couple tough months. But I would also add, that that can change fairly quickly if the milk price gets low enough. And it’s certainly a ratio of farm economics over a certain period of time and milk price. If it gets low enough and makes those farm economics adverse enough, it can expedite the issue, which is a plausible scenario right now. Ted Jacoby III: Mm-hmm. I would agree with that. I think the hardest thing, especially when you have a falling market like we do right now, is to try and figure out exactly where the bottom is. About a month ago, the bottom was about a $1.40. Well, guess what? Cheese price is already below a $1.40 Now, we’re hearing it’s gonna be [00:06:00] somewhere in the $1.20s. What I’m scared is we’re gonna get to the $1.20s, and somebody’s gonna start talking about maybe we need to go into the teens. I don’t know if we’re gonna go that low, but we’re definitely in that scenario right now, where you have a market that’s falling and nobody has a really good feel for where that bottom is. Gus Jacoby: I agree. Cheese and butter right now, their outlook over the next six to eight months does not look good. Ted Jacoby III: Yeah. You mentioned butter. Joe, I’ll ask you: we’re below a $1.50 in butter. Butter feels like maybe it’s caught a temporary floor. Is this a temporary floor or could we stabilize here for the next six months? Joe Maixner: I think we’ve hit a temporary floor, but I don’t think it’s the lowest we’ll see over the next 90 days. I think that cream seems to be in balance, even after Thanksgiving, and I think it’s kept a nice spot in the market where people are willing to buy, those that hadn’t already put contracts on for next year are seeing the 2026 numbers and they’re looking at that against their budgets and blocking volume up for next year. A [00:07:00] lot of first half volume’s already been booked. We’re just seeing more activity. We’ve hit that level of support. Ted Jacoby III: Joe, you mentioned cream. Gus, I’m gonna go back to you. We had some really ugly cream multiples the first half of last year. Have we increased churn capacity, and do we expect those multiples to be just as bad this year or have we increased churn capacity enough so that maybe they won’t quite get so bad? Gus Jacoby: We have increased churn capacity, certainly. I don’t know if it’s enough. Some dairymen around the country are feeding their rations a bit different and getting a little bit less butterfat out of the milk. I don’t think that’s enough, yet, to make too much change. I will anticipate having some very low multiples through the holidays and the spring flush. Ted Jacoby III: Okay. Diego, I’m gonna switch gears and come to you. We just talked about U.S. milk production. Gus thinks it’ll take about six months to turn. I hate to be really pessimistic, but my gut, and I just can’t shake this gut, is it’s gonna take longer than usual this time around. And we may see it go well past nine months before we see a real turn. [00:08:00] We may see the number get better simply because we’re measuring against strength, but that doesn’t mean we actually see a change in trend. What about Europe and some of the other milking regions in the world, is it gonna take that long us to see some changes in milk production in those regions? Diego Carvallo: If you just go to the fundamentals and you analyze that the European farmer usually has a smaller scale, and that means that their costs tend to be a little bit on the higher end. They do not have access to capital as there is in the U.S. There’s more restrictions when it comes to environmental, and overall I would say they have more headwinds than the U.S. So, if you add to all of those headwinds, the price headwind, the reaction on milk production to lower prices should be faster than in the U.S. The same applies to South America. But we’ve talked a lot about Chinese production, we know that in that country, there are way more things to take into account. Ted Jacoby III: [00:09:00] So, we’ve been talking a lot about the supply side today. We’re just overwhelming supply on the butter side; we’re overwhelming demand to a lesser extent, but still on the cheese side. Josh, protein still tends to be the shining star. But are we getting to a point where we’re starting to get some pushback on protein prices? And is that going to continue to be the lone bull in an overall bearish dairy market, or do we need to be concerned there too? Josh White: I don’t think we’re getting pushback at the prices quite yet. Does that mean I think that these prices are palatable over the long term? I’m unsure. But what we are seeing right now is lack of availability and no quick ability by the European market or the U.S. market to scale production to meet the demand, which means that ultimately, the demand for WPC 80 and WPI and then some of the more value-added proteins, particularly in the whey complex, like the clear WPIs, the acidified products and others, the demand is outpacing our ability to supply it. What that’s [00:10:00] doing is forcing utilization segments or customers that can’t compete in terms of price for that available supply to look to alternatives. We’re starting to see more and more of that. As a commodity trader, we expect that to happen quicker than it does. So, already in early 2025, we were looking towards MPCs, casein-related products and others to pick up some of that demand because they’re much lower value. And I don’t think that the average customer in the market that’s using whey proteins fully recognize the functional differences between whey proteins and milk proteins. And they certainly don’t realize that milk protein concentrate has whey protein in it. Generally speaking, the average consumer doesn’t know the difference in these products. That’s not a fault of theirs. Particularly going into CPG applications and further processing, this is an ingredient. An ingredient that has a lot of label recognition and popularity right now for all the reasons we’ve talked about in prior podcasts: GLP-1 driven demand, [00:11:00] health and wellness movements globally, a lot of other reasons. Is that an early indication that enough time has now passed that the relative value of whey protein above the competing, but still quite valuable proteins in the dairy complex, are gonna result in substitution both substitution within the dairy category to whey protein to milk protein concentrates to micellar casein to WPC 70, also known as WPPC, whey protein phospholipid concentrate (WPPC) ProCream. There’s a lot of different names for these products. That’s likely to happen. But it also, unfortunately, might result in a lot of categories pushing to non-dairy proteins. There’s a lot of information out there, things put on by ADPI and others talking about the protein power of dairy and how digestible it is. How high quality it is for your conversion rate, why it’s such a popular thing. But if you can’t get supply, you’re forced to look to alternatives. And so, we’re starting to see some of that [00:12:00] happen. So, a couple things that I’ve heard anecdotally in the market over the past few weeks in particular, but it’s been happening over the last few months are: get us samples of milk protein concentrate. One of our customers is suspending a certain SKU on the shelf because they can’t get the supply. This price simply won’t work for our application. So, we won’t buy this product at above this price. So, we are triggering some thresholds. And triggering thresholds is gonna have some type of balancing result in the industry. Whether that’s enough to support the milk protein side of the equation, I don’t know. We have a limit to the ability to respond to this demand. You have to order equipment, you have to get the bank lending, you’ve gotta get the design. It takes a long time to increase capacity. That’s all gonna come into play and impact this market and the balance of this market in 2026. Now, if you’re asking me, is my gut that we hold these high prices or even higher prices without some reversal in the price [00:13:00] action for whey proteins in 2026? I’m not ready to say that it’s just here or higher in 26, but is it here or higher in the first quarter? Absolutely. Is it here higher in the second quarter, probably. Is it here or higher after that? I become a little bit skeptical. And to be clear, that’s not because the demand isn’t there right now. The demand feels like it’s there. I just don’t know how the market balances it out without pushing the price just too high in the short term for the market to digest it and pass it through. I also think that when you’re talking about the dairymen and you’re talking about the cheese makers, there is two different classes here. There is the class of those that make whey proteins and the class of those that do not. That has a material impact on profitability throughout the supply chain. Additionally, we’ve got a lot of milk in the U.S. We’ve got a lot of milk in the world right now, and the milk in the Northern hemisphere altogether is only gonna increase from here through the first half of [00:14:00] the year. That milk is gonna need to be processed. The incremental milk production will result in incremental whey protein availability, which means that those whey solids from cheese processors they have to find a market. If you can’t make the valuable product of WPC 80 and WPI, you have to explore the other alternatives, which are simply not experiencing the robust demand of those two categories. Sweet whey powder, whey protein concentrate 34% (WPC 34) and some of these other products, they have a limit to what people are willing to pay. History tells us, at least for sweet whey powder, we’re testing those limits. Ted Jacoby III: For sweet whey powder, we are, the question is, is this happening for whey protein? And that’s a harder one to answer. Josh White: Absolutely. Ted Jacoby III: I did some back of the envelope math. As a country, we produce 8% to 9% more milk in May on a daily basis than we do in November. If half of that milk goes into cheese, we’ll produce 8% more cheese and 8% perhaps more whey protein. The solids change, too. So, maybe it’s not a full [00:15:00] 8%, but is 8% enough to tip the scale on whey protein demand? And I don’t know, given the demand complex for whey, I think for cheese it’s gonna feel very burdensome. I think for butter, it would probably feel pretty burdensome. The butter market we’re kind of used to it because of the way the demand curve looks, but I just don’t know when it comes to whey, if that’s enough to put some pressure on this market and bring those prices down. Josh White: Well, it depends on what you’re talking about because you could argue that the WPC and WPI facilities are bringing in outside whey solids. Mm-hmm. Mm-hmm. As their own milk and their own whey generation increases seasonally, that’s gonna push whey solids back to somebody else. So, all 8% in your hypothesis there, I doubt contributes to an 8% increase in whey protein production. Because the available capacity isn’t there? Josh White: Correct. Now, is there production efficiencies that are still gonna be gained? Are there those out there that are expanding a bit [00:16:00] that we’re unaware of? Are there orders for new equipment in the system that might be closer to realization than we think? All possible. And we can’t ignore Europe. I don’t feel like I can adequately represent what the expansion model looks like in Europe right now for whey proteins. What I can say is that at least for the U.S. and Europe, our internal demand is currently absorbing a greater percentage of our production than ever before, and that’s leaving the rest of the world that was buying product from those two markets, having to search for that protein elsewhere. Ted Jacoby III: Mm-hmm. Josh White: And, this is being a bit over generic, but the rest of the world likely will be more willing to substitute than the U.S. or the European consumer to other products. Ted Jacoby III: I would agree with that. Everybody in our office is just leaning really bearish, just about everybody we talk to seems to be leaning really bearish. Josh White: Outside of Black Swan events: major trade disruptions, major production impacts that we can’t predict. If you’ve [00:17:00] been in the dairy industry long enough, you know to never bet against the dairymen and their ability to make milk. But it’s gotta be on the radar that the competitive dollars for those animals I don’t think has ever been as lucrative as it is right now. And those animals that they’re currently milking are older then typically they want them to be. So, if we shift this cycle quickly enough and violently enough, and that’s price, at what moment do we get surprised at what that residual response is? How many pent up animals find their way to slaughter? How quickly that could happen. And I think generally speaking, most of us would bet that the calf inside the dairy cow right now is worth enough to wait. And so, we’ve gotta get through the first half of the Northern Hemisphere season before we see much of an animal response. Ted Jacoby III: I think that’s a fair comment. Dairy farmers, especially the big financially astute ones, there’s a math equation. It’s like, this is my revenue [00:18:00] from milk. This is my maybe revenue from biofuels or wherever else. They have revenue streams from a cow that’s giving milk every day. This is the cost to maintain that cow. The variable cost feed, for example, being the big one. Well, when you’re getting $20, a hundredweight from your milk versus $13, a hundredweight for your milk. That equation has changed quite a bit, whereas the exit price, what you’re gonna get if you sell the cow hasn’t changed at all, which means your math equation, the exit possibility has definitely gone up. It’s more profitable to sell this cow than it used to be. Josh White: History tells us that the exits of the older dairymen and the smaller dairies doesn’t really change based on economic conditions, it’s relatively stable. Maybe there’s some risk that we have some pent up exits and some risk that it’s never been a better time to retire. Mm-hmm. And you get some smaller dairies that decide to exit. That doesn’t move the needle. Ted Jacoby III: I would suspect. You’re right. We’ll see. Josh White: One [00:19:00] quick remark that’s important is the outlook on demand. It seems like the market is very, very bearish because supply is outpacing demand globally and it’s in every major milk shed. But demand by import regions has been pretty good. Mm-hmm. They’ve been buying year over year, more dairy products. At the same time, I don’t believe there’s any region in the world that’s currently sitting on cumbersome overall dairy stocks, whether that’s from the import regions or the production regions. Everyone seems to be quite aware that you gotta stay in front of this. I don’t know how to interpret that. On one hand, you could say that based on some of the economic outlooks, globally, we shouldn’t be expecting things to get better. We should be expecting them to get at best the same or possibly even worse. On the other side of that equation is import dairy consumption and demand is growing and continues to grow, so it might be a painful period, but the long-term [00:20:00] outlook remains pretty good, and we just overreacted to some of the demand signals that we have. Credit to the dairymen in the world, being able to respond to signals that we needed more fat, not even a year ago. That whey protein demand’s good. I mean, the market has responded, but overall we’re not talking about an oversupply situation because demand’s bad. If you go granularly, like U.S. cheese consumption, doesn’t look real great right now. The outlook for overall economic health, I’m not an expert in that area, but I’m not seeing a lot of people talking about a rosy 12 to 24 months there. So, yeah, I think generally speaking, it’s easy to be bearish, but maybe that’s one thing to pay attention. Ted Jacoby III: You mentioned demand. I happened to be involved in a conversation yesterday with an equities trader and his comment about stock valuations, equities, valuations, which was really a demand comment, was, I’m just waiting to see what Christmas sales do. I think there’s a lot of people out there right now that are trying to get a feel for what’s [00:21:00] the long-term demand or the 2026 demand perspective, and I think a lot of them are gonna judge what it really is based on how this holiday season plays out. All right guys. Hey, thanks for a great conversation. I apologize to all the dairy farmers out there that I couldn’t give you any better news, but hang in there that good news will come eventually. That’s right.

CME credits: 1.00 Valid until: 11-12-2026 Claim your CME credit at https://reachmd.com/programs/cme/Hepatic-Encephalopathy-More-Common-Than-You-Think/39786/ This series of brief episodes focuses on the early recognition and clinical management of hepatic encephalopathy (HE). Drs. Arun Jesudian and Nancy Reau examine subtle signs that may indicate minimal or covert HE and offer strategies for timely diagnosis. The discussion covers practical tools for detection, the role of nutrition and pharmacologic therapy, and evidence-based approaches to prevent progression and hospitalization. Emerging therapies and ongoing clinical trials are also discussed to highlight future directions in HE treatment.

Featuring an interview with Dr John V Heymach, including the following topics: Differentiating factors among various HER2 alterations in non-small cell lung cancer (NSCLC) (0:00) Activity of targeted agents across HER2 alterations in NSCLC (4:06) Available data with zongertinib and sevabertinib for HER2-mutant NSCLC (20:39) Case: A man in his late 40s with HER2-mutant NSCLC receives multiple lines of therapy, including trastuzumab deruxtecan (T-DXd) and zongertinib (29:23) Case: A woman in her mid 50s with HER2-mutant NSCLC receives zongertinib with durable response (34:23) Case: A woman in her late 50s with HER2-mutant NSCLC receives multiple lines of therapy, including sevabertinib and T-DXd (39:53) Investigational approaches in HER2-mutant NSCLC (46:31) CME information and select publications

Burnout prevention advice rarely works for practice owners because it ignores the structural realities of running a healthcare business. Generic wellness tips like "set better boundaries" or "take more vacations" fall flat when you're responsible for payroll, team development, and practice sustainability. In this episode, Tracy breaks down why traditional burnout prevention fails and shares three strategic pillars that actually address the root causes of depletion for independent practice owners.  Click here for full show notes  Is your practice growth-ready? See Where Your Practice Stands: Take our Practice Growth Readiness Assessment  Drawing from a powerful CME wellness workshop in Silicon Valley, Tracy explores the generational divide emerging around burnout—younger physicians drawing hard lines about sacrifice while seasoned physicians grapple with whether to perpetuate the moral injury they've experienced. The conversation reveals how we've normalized exhaustion as a badge of honor and built healthcare systems that require sacrifice. But it doesn't have to be this way.  Episode Highlights:  Why employed physicians may actually be at higher risk for burnout than practice owners—and what that reveals about autonomy and agency  The "frog in boiling water" reality: how for-profit insurance since the 1970s has gradually conditioned physicians to accept unsustainable conditions  Time Leadership vs. Time Management: why optimizing your calendar won't solve burnout if you're working on the wrong things  The $10 vs. $100 task framework: how to stop spending expert-level time on basic tasks  Three essential questions for sustainable growth decisions: "Only me? Today? Someone else?"  Why "slow down to speed up" isn't just a platitude—it's the foundation of strategic practice leadership  How clarity creates speed while haste creates chaos (and why American hustle culture gets this backwards)  The connection between business systems and wellbeing: why you can't separate practice sustainability from personal sustainability  Memorable Quotes:  "Time management is about getting more done. Time leadership is about getting the RIGHT things done."  "Real leadership is building systems that don't depend on your heroic effort."  "Growth without sustainability isn't growth—it's extraction."  "Clarity equals speed. Lack of clarity equals chaos and plate-spinning."  "Prevention isn't about bubble baths and boundaries. It's about strategic changes to how you lead your time, build your systems, and approach growth."  "You didn't create this system. You've been adapting to survive in it—one small compromise at a time, one policy change at a time, one administrative burden at a time."  "If 'all hands on deck' is happening weekly, it's time to re-examine some things."  This episode is essential listening for practice owners who recognize themselves in the exhaustion phase and want to make strategic changes before burnout progresses. Prevention is so much easier than recovery—and it starts with understanding that your wellbeing and your business success aren't separate challenges.  Tracy's Bio:  Tracy Cherpeski, MBA, MA, CPSC (she/her/hers) is the Founder of Tracy Cherpeski International and Thriving Practice Community. As a Business Consultant and Executive Coach, Tracy helps healthcare practice owners scale their businesses without sacrificing wellbeing. Through strategic planning, leadership development, and mindset mastery, she empowers clients to reclaim their time and reach their potential. Tracy designs and delivers CME-accredited wellness retreats and workshops in partnership with medical associations, bringing burnout prevention and sustainable practice management to physicians nationwide. Based in Chapel Hill, NC, Tracy serves clients worldwide and is the Executive Producer and Host of the Thriving Practice podcast. Her guiding philosophy: Survival is not enough; life is meant to be celebrated.  Connect With Us:  Be a Guest on the Show  Thriving Practice Community  Schedule Strategy Session with Tracy  Tracy's LinkedIn  Business LinkedIn Page 

Neurologists are privileged to act as guides for patients as they navigate the complex course of serious neurologic illnesses. Because of the impact on quality of life, personhood, and prognosis, neurologists must be able to conduct serious-illness conversations to improve rapport, reduce patient anxiety and depression, and increase the likelihood that treatment choices agree with patient goals and values. In this episode, Teshamae Monteith, MD, FAAN speaks with Jessica M. Besbris, MD, author of the article "The Approach to Serious-Illness Conversations" in the Continuum® December 2025 Neuropalliative Care issue. Dr. Monteith is the associate editor of Continuum® Audio and an associate professor of clinical neurology at the University of Miami Miller School of Medicine in Miami, Florida. Dr. Besbris is an assistant professor of neurology and internal medicine, and the director of the neuropalliative care, at Cedars-Sinai Medical Center in Los Angeles, California. Additional Resources Read the article: The Approach to Serious-Illness Conversations Subscribe to Continuum®: shop.lww.com/Continuum Earn CME (available only to AAN members): continpub.com/AudioCME Continuum® Aloud (verbatim audio-book style recordings of articles available only to Continuum® subscribers): continpub.com/Aloud More about the American Academy of Neurology: aan.com Social Media facebook.com/continuumcme @ContinuumAAN Host: @headacheMD Guest: @JessBesbris Full episode transcript available here Dr Jones: This is Dr Lyell Jones, Editor-in-Chief of Continuum. Thank you for listening to Continuum Audio. Be sure to visit the links in the episode notes for information about earning CME, subscribing to the journal, and exclusive access to interviews not featured on the podcast. Dr Monteith: Hi, this is Dr Teshamae Monteith. Today I'm interviewing Dr Jessica Besbris about her article on the approach to serious illness conversation, which is found in the December 2025 Continuum issue on neuropalliative care. How are you? Dr Besbris: I'm doing great. Thank you so much for having me here today. Dr Monteith: Well, thank you for being on our podcast. Dr Besbris: My pleasure. Dr Monteith: Why don't we start off with you introducing yourself? Dr Besbris: Sure. So, my name is Jessica Besbris. I am a neurologist with fellowship training in palliative care, and I am currently at Cedars Sinai Medical Center in Los Angeles, where I am the director of our neuropalliative care program. Dr Monteith: Excellent. So, how did you get involved in that? Dr Besbris: Like, I think, many neurologists, I always knew I wanted to be a neurologist---or, I should say, from the moment I decided to be a doctor I knew that that was the type of doctor I wanted to be, a neurologist. So, I went into medical school with the aim of becoming a neurologist. And very quickly, when I started my clinical years, I was exposed to patients who were living with very serious illnesses. And I found myself really drawn to opportunities to help, opportunities to make people feel better, opportunities to improve quality of life in situations that on the face of it seemed really challenging, where maybe it seemed like our usual treatments were not necessarily the answer or were not the only answer. And so, I pretty quickly recognized that taking care of patients with serious illness was going to be a big part of my life as a neurologist and that palliative care was the way I wanted to help these patients and families. Dr Monteith: And you mentioned you're leading the group. So, how many colleagues do you have in the program? Dr Besbris: We have a very large palliative care group, but within neuropalliative care, it's myself and one other physician, a nurse practitioner, and a social worker. Dr Monteith: Okay, well, I know you guys are busy. Dr Besbris: Yes, we are very happy to be busy. Dr Monteith: Yes. So, let's talk about the objectives of your article. Dr Besbris: Sure. So, the goal of this article is to impress upon neurologists that it really is all of our jobs as neurologists to be having these conversations with our patients who are affected with serious illness. And then, in most areas of neurology, these conversations will come up. Whether it's giving a life changing diagnosis, or talking about treatment choices, or treatment not going the way that we had hoped, or even sometimes progression of disease or end-of-life care. These topics will come up for most of us in neurology, and really, we're hoping that this article not only makes the case that neurologists can and should be having these conversations, but that there are skills that we can teach in this article and with other resources to improve the skill level and sense of confidence that neurologists have when they enter into these conversations. Dr Monteith: Great. I read that there are some developments in the field, on organizational levels, about really making these skills part of standard of care in terms of education. So, can you speak to that? Dr Besbris: Yes. So, there have been a couple of really landmark papers and changes in the educational landscape that I think have really brought neuropalliative care in general, and serious illness conversation in particular, to the forefront. So, there were the position statements released by the American Academy of Neurology in 1996 and 2022, both of which really said, hey, all neurologists should be doing this and receive training on how to have these conversations and provide this care. And the ACGME, the Accreditation Council for Graduate Medical Education, also requires neurology residency programs to learn how to communicate with patients and families, assess goals, and talk about end-of-life care. So, there's a real structural imperative now for neurologists to learn early on how to have serious illness conversations with their patients. Dr Monteith: Great. If there's anything for our listeners to get out of this conversation, what are the essential points? Dr Besbris: If you only take away one or two things from this conversation, I hope that they're that this is an awesome responsibility to be in a moment with a patient going through something challenging, to meet them in that moment with thoughtful, honest, empathic conversations about who they are and what's important to them. And that, just like any other procedure, these are skills that can be taught so that you can feel really confident and comfortable being in these moments. Dr Monteith: Excellent. Wow. Okay, I feel your energy and your empathy already. And so, why don't we just talk about skills? What is the best way to deliver tough news? I read this wonderful chart on SPIKES protocol. Dr Besbris: Yeah, the SPIKES protocol is one really well-known way to deliver serious news. And what's nice about SPIKES is it gives a mnemonic. And as neurology learners, we all love a good mnemonic to help you really center yourself when you're entering into these conversations so that you have a structured format to follow, just like with any procedure. So, the SPIKES protocol stands for Setting: so, making sure you have the right environment; Perception, or assessing what your patient or surrogate decision maker knows already so that you know where to begin; receiving an Invitation to deliver serious news. And then K stands for Knowledge, delivering in a clear and concise way the information that you want to make sure the family or patient walk away with. E for exploring Emotion; and S for really Summarizing what's been discussed and Strategizing on next steps. I think that having these kinds of conversations, it's just like being expert in anything. When you first start learning, it's helpful to have a set of very concrete steps you can follow. And you might even think through the mnemonic as you get ready to walk into that room. And as you become more expert, the flow becomes more natural. And maybe what you do before walking in to prepare is just honing what is that headline? What is that concise statement that I'm really going to give? And the rest may start to feel more natural and less protocolized. Dr Monteith: And there are a few other mnemonics. There's the NURSE mnemonic, which I like. You know, there's a balance between saying things and sounding kind of… you know, sometimes they're like, well, how could you understand what I'm going through? Have you been through something like this? And people shy away, and they're afraid to kind of be a part of these conversations. So how do we approach that with this, a NURSE mnemonic in a way that's kind of sincere? Dr Besbris: Absolutely. So, the NURSE mnemonic, unlike SPIKES, is not a step-by-step protocol. So, NURSE is a mnemonic, but you don't go through each letter and sort of give a naming statement and then an understanding statement and then a respecting statement and so on. Nurse is really a toolkit of different types of statements that we can give in response to emotions so that when you find yourself in a situation where a patient or family member is tearful, is scared, is angry, is expressing feelings, you have some phrases ready that feel authentic to you and that you feel are going to meet the moment and allow you to empathically respond to those emotions. Because until we do that, we really can't move further in this conversation with our patients and families feeling heard and respected. So, that NURSE mnemonic, those Naming, Understanding, Respecting, Supporting and Exploring statements, are really examples of statements that we can use to meet that moment with empathy and understanding and without implying that we have walked in their shoes. We want to avoid being presumptuous and really focus on just being present and empathic. Dr Monteith: So, let's just kind of run through, I think it's really important. Let's run through some of these examples. Maybe if someone's crying hysterically, how would we respond to that? Dr Besbris: So, this is an opportunity for Naming. And I made this one, I think, in the chart, a little bit obvious, meaning that we recognize when someone is crying that they are feeling probably very sad. This is an opportunity for us to name and thus normalize that emotion. I just think something as simple as, I think anyone would be really sad hearing this. These responses are not intended to fix this emotion. I'm not trying to get someone to stop crying or to, you know, necessarily not feel sad. It's really just to say, yeah, it's normal that you're feeling sad. It's okay. I'm here with you while you're feeling sad. And I'm going to be with you no matter what you're bringing to the table. Dr Monteith: Yeah. Let's go through just a couple of others. I mean, these are really good. Dr Besbris: Sure. Maybe Respecting. Dr Monteith: Yeah. So, my Dad is a fighter. Only God, not doctors, can know the future. Dr Besbris: Yeah. So, I love giving these examples with our learners because these statements, things like my Dad is a fighter or God will bring me a miracle or you don't know the answer. Only God knows what's going to happen, I think that they give a lot of doctors a feeling of confrontation, a feeling of anxiety. And I think there are a few reasons for that. And I think one of the main ones is that they're statements that imply that we as doctors are not all-powerful and it's our patients or families sort of looking for a different locus of control, whether it's internal fortitude or a higher power. They're looking to something other than us, and maybe that makes us feel a little bit uncomfortable. And I think that sometimes physicians think that these statements imply that someone doesn't even understand what's going on. But maybe they're coming to this from a place of denial. And I would argue that when someone comes to you with a statement like my dad is a fighter or, you know, I'm looking to God to bring me a miracle or to show me the future. I think that what they're really saying is, wow, I'm really hearing that things are serious, so much so that I'm reaching for these other resources to give me strength and hope. I don't think anyone asks for a miracle if they think that a miracle is not needed, if the problem is easy to fix. And so, rather than come to these types of statements from a confrontational place of I'm the doctor and I know best, I think this is a great opportunity to show some respect and give some respecting statements. Your dad is a fighter. I don't think he could have come this far without being a fighter. Or, you know, I am so grateful that you have your faith to lean on during times like these to give you strength. These are also nice opportunities for exploring statements. For example, I'm so grateful to learn more about your dad. Can you tell me what it is that he has been fighting for all of this time? Dr Monteith: I love that. It's like a follow-up, and also validating. Dr Besbris: Yeah, it's validating. And it allows us to learn a little bit more about this person and to learn, well, is he fighting for a life that we can still achieve with our interventions to lead into the next part of a conversation? Or, is God is going to bring me a miracle? Well, tell me what a miracle looks like for you. I can't tell you how many times I thought someone was going to tell me that a miracle would be cure. And sometimes that is what comes up. But other times I hear, a miracle would be, you know, my loved one surviving long enough for the rest of the family to gather. And, you know, that is certainly something we can work towards together. Dr Monteith: So, why don't we talk a little bit about approach to goals of care discussions? They are tough, and let's just put it into perspective to the critical care team. It's time, the person's been in the ICU, the family wants everything thrown at medically. And it's to the point that the assessment is that would be medical futility. Dr Besbris: Lots to unpack there. Dr Monteith: I wanted to make it hard for you. Dr Besbris: No, no, this is good! I mean, this is something- I work in a, you know, almost one thousand-bed hospital with a massive critical care building. And so, these are not unusual circumstances at all. First of all, I would just say that goals of care conversations are not only about end-of-life care. And I make that point a few different times in the article because I think when people imagine goals of care, and one of the reasons that I think clinicians may sometimes shy away from goals of care discussions, is that they think they have to be sad, they have to be scary, they have to be about death and dying. And I would argue that, really, goals of care discussions are about understanding who a person is, how they live their life, what's most important to them. Most of these conversations should be about living. How are we going to together achieve a quality of life that is meaningful for you and treatments that are going to fit your needs and your preferences? But there is a little slice of that pie in the pie chart of goals of care discussions that is in the arena of end-of-life care. For example, ICU care with, really, the highest levels of intensity of care, and having to talk about whether that still is meeting the moment from the perspective of goals as well as the perspective of efficacy. So, from the goals standpoint, I approach these conversations just like any other goals of care conversation. Usually at this point, we're speaking to family members and not our patients because in a neurocritical care unit, if someone is that sick, they probably are incapacitated. And so, it's a moment to really sit down with family and say, please tell me about the human being lying in that bed. They can't introduce themselves. What would they tell me about themselves if they could speak right now? What kinds of things were important to them in the course of their treatment? What kind of a life did they want to live or do they want to live? So that then we can reflect on, well, can our treatment achieve that? And this process is called shared decision making. This is really where we take in data from the family, who are experts in the patient, and then our own expertise in the illness and what our treatments can achieve, and then bring all of that information together to make a recommendation that aligns with what we believe is right for a particular patient.  So, in the example that you gave, the extreme circumstance where someone is receiving maximal intensive care and we're starting to reach the point of futility, I think that we need to first really understand, well, what does futility mean for this particular patient? Is it that we as healthcare providers would not value living in the state this person is in? Or is it that the treatments truly cannot physiologically keep them alive or meet their stated goals? If it's the first one, that I wouldn't want to be on machines unconscious, you know, at the end of my life, well, I have to set that aside. It's really about what this patient wants. and if the family is telling you they valued every breath, every moment, and if we have care that can achieve that, we should continue to offer and recommend that care. And as healthcare providers, it is so important that we do explain when treatments are not going to be able to physiologically meet a patient's needs or achieve their goals. And that's where we can say, I'm going to continue to do everything I can, for example, to, you know, keep your loved one here for these meaningful moments. And we are at a point where performing CPR would no longer be able to restart his heart. And I just wanted to let you know that that's not something that we're going to do because I have an obligation not to provide painful medical treatments that will not work. So, my approach to futility is really different than my approach to shared decision-making because in the context of objective futility, it's not about necessarily- it's not about decision-making, it's not about shared decision-making as much as it is explaining why something is simply not going to work. Does that make sense? Dr Monteith: Absolutely. And what I love in your article is that, you know, you go beyond the skills, but also potential communication challenges---for example, patients' neurologic status, their ability to understand complex communication, or even cultural differences. So, can you speak about that briefly? Dr Besbris: Absolutely. In the world of neurological serious illness, it is incredibly common for our patients to face challenges in communication. That might be because they are aphasic, because they have a motor speech deficit, it might be because they're intubated, it might be because their capacity is diminished or absent. And so, there are a lot of challenges to keeping patients in these conversations. And in the article, I summarize what those challenges can look like and some strategies that we can use to continue to engage our patients in these conversations to the greatest extent possible and also turn to their surrogate decision makers where the patients themselves are no longer able to participate or participate fully. In terms of cultural considerations, I mean, there could be an entire article or an entire Continuum just on cultural considerations in neurology and in serious illness communication. And so, the key points that I really tried to focus on were exploring from a place of cultural humility what the beliefs and practices of a particular patient and family are in their cultural context, to ask questions to help you understand how those cultural differences may impact the way you approach these conversations. And being sensitive to folks with limited English proficiency, to ensure that we are using medical interpreters whenever possible. Dr Monteith: Excellent. Well, there's so much in the article. There's already so much that we just discussed, but our listeners are going to have to go to the article to get the rest of this. I do want to ask you to just kind of reflect on, you know, all the different cases and experiences that you have, and just, if you can give us a final remark? Dr Besbris: I can think of a number of cases that I've seen in my work as both an inpatient and outpatient neuropalliative provider where I've seen patients after strokes in the hospital with uncertain prognosis, whose families were struggling with a decision around feeding tubes. And where we have made a determination based on goals; for example, to pursue what's called a time-limited trial, to say let's place a feeding tube, let's meet again in the clinic in a few months after some rehab and let's just see, is this meeting this patient 's goals and expectations? I have been pleasantly surprised by the number of patients who have walked into my office after a period of rehabilitation who have regained the ability to eat, who are living an acceptable quality of life, and who have expressed gratitude for the work that I did in eliciting their goals, helping support their families. And some of whom have even come in and said, now that I'm doing better, I'd really like to do an advance directive to better guide my family in the future. People asking for more goals of care discussions, having seen how successful and helpful these conversations have been. Dr Monteith: Great. That's really life-altering for that patient, the family, so many people. Thank you so much for the work you do and for writing this great article and sharing all of this that we really need to learn more about. Dr Besbris: It's been a privilege. Thank you so much for talking with me today. Dr Monteith: Today I've been interviewing Dr Jessica Besbris about her article on the approach to serious illness conversation, which is found in the December 2025 Continuum issue on neuropalliative care. Be sure to check out Continuum Audio episodes from this and other issues. And thank you to our listeners for joining today. Dr Monteith: This is Dr Teshamae Monteith, Associate Editor of Continuum Audio. If you've enjoyed this episode, you'll love the journal, which is full of in-depth and clinically relevant information important for neurology practitioners. Use the link in the episode notes to learn more and subscribe. AAN members, you can get CME for listening to this interview by completing the evaluation at continpub.com/audioCME. Thank you for listening to Continuum Audio.

Dr John Heymach from The University of Texas MD Anderson Cancer Center in Houston discusses recent updates on available and novel treatment strategies for HER2-altered non-small cell lung cancer. CME information and select publications here.

This episode is sponsored by Lightstone DIRECT. Lightstone DIRECT invites you to partner with a $12B AUM real estate institution as you grow your portfolio. Access the same single-asset multifamily and industrial deals Lightstone pursues with its own capital – Lightstone co-invests a minimum of 20% in each deal alongside individual investors like you. You're an institution. Time to invest like one.-------------------------------------------What do you do when a colleague needs coaching but resists every step? In this essential episode for physician leaders, host Dr. Bradley Block welcomes back Dr. John Schneider, as they explore starting productive conversations with those who don't want to hear it: from remediation for below-standard behavior to subtle issues. Dr. Schneider stresses asking questions from their perspective, building psychological safety, and inviting participation to open doors for change, not pushing through them. He warns against "hammer" approaches like HR escalation unless minimum competencies fail, and shares the "challenge plus support" quadrant: challenge without support leads to retreat; support without challenge stalls growth. Drawing from his roles as Assistant Dean for Faculty Coaching and private practice coach, he emphasizes leading with belief in people, connecting to their original "calling" in medicine, and accepting that not everyone will walk through the door. If you're in leadership facing resistance. This episode offers nuanced, practical strategies to foster trust, inspire evolution, and avoid burnout for you and your team.Three Actionable Takeaways:Start with Their Perspective, Not Yours: When addressing resistance, ask questions that uncover what they need, not what you think they need. Avoid starting from remediation or "hammer" tactics; build psychological safety by showing you believe in them, inviting participation to make change feel meaningful and voluntary.Balance Challenge and Support for Growth: Use the quadrants: Challenge without support causes retreat; support without challenge leads to stagnation. As a leader, consciously provide both, holding accountable while being "with them" to open doors for self-reflection and behavior shifts, even if they don't always step through.Reconnect to Their Original Calling: Remind resistant colleagues of why they chose medicine, the inspiration that's often buried under policies and metrics. Frame changes as ways to rediscover that purpose, making evolution feel like a personal win, not an imposed fix; not everyone changes, but this invites possibility.About the Show:Succeed In Medicine  covers patient interactions, burnout, career growth, personal finance, and more. If you're tired of dull medical lectures, tune in for real-world lessons we should have learned in med school!About the Guest: Dr. John Schneider is the Division Chief of Rhinology and Anterior Skull Base Surgery and Associate Professor at Washington University in St. Louis. He serves as the university's first Assistant Dean for Faculty Coaching and is a Master Certified Physician Development Coach. In addition to his academic and clinical roles, Dr. Schneider runs his own coaching practice called Physicians' Mind Coaching, focused on helping physicians improve self-awareness, leadership, communication, and professional fulfillment. He is a nationally recognized expert in physician coaching, particularly in having difficult conversations, addressing disruptive behavior, building psychological safety, and guiding reluctant physicians toward personal and professional growth. He trains faculty coaches at Wash U and frequently speaks on topics including conflict resolution, the coach approach in leadership, and burnout prevention.Email:   john@physiciansmind.comAbout the Host:Dr. Bradley Block – Dr. Bradley Block is a board-certified otolaryngologist at ENT and Allergy Associates in Garden City, NY. He specializes in adult and pediatric ENT, with interests in sinusitis and obstructive sleep apnea. Dr. Block also hosts Succeed In Medicine podcast, focusing on personal and professional development for physiciansWant to be a guest?Email Brad at brad@physiciansguidetodoctoring.com  or visit www.physiciansguidetodoctoring.com to learn more!Socials:@physiciansguidetodoctoring on Facebook@physicianguidetodoctoring on YouTube@physiciansguide on Instagram and Twitter This medical podcast is your physician mentor to fill the gaps in your medical education. We cover physician soft skills, charting, interpersonal skills, doctor finance, doctor mental health, medical decisions, physician parenting, physician executive skills, navigating your doctor career, and medical professional development. This is critical CME for physicians, but without the credits (yet). A proud founding member of the Doctor Podcast Network!Visit www.physiciansguidetodoctoring.com to connect, dive deeper, and keep the conversation going. Let's grow! Disclaimer:This podcast is for informational purposes only and is not a substitute for professional medical, financial, or legal advice. Always consult a qualified professional for personalized guidance. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

If you're a physician with at least 5 years of experience looking for a flexible, non-clinical, part-time medical-legal consulting role… ...Dr. Armin Feldman's Medical Legal Coaching program will guarantee to add $100K in additional income within 12 months without doing any expert witness work. Any doctor in any specialty can do this work. And if you don't reach that number, he'll work with you for free until you do, guaranteed. How can he make such a bold claim? It's simple, he gets results…  Dr. David exceeded his clinical income without sacrificing time in his full-time position. Dr. Anke retired from her practice while generating the same monthly consulting income.  And Dr. Elliott added meaningful consulting work without lowering his clinical income or job satisfaction. So, if you're a physician with 5+ years of experience and you want to find out exactly how to add $100K in additional consulting income in just 12 months, go to arminfeldman.com.                                                          =============== This podcast is sponsored by the Physician Executive MBA Program at the University of Tennessee Knoxville's Haslam College of Business. Thinking about a nonclinical career path? In just one year, our physician-only MBA gives you the business and leadership skills to pivot, whether into administration, consulting, entrepreneurship, or beyond. Join a nationwide network of over 1,000 physician leaders. Learn more at nonclincicalphysicians.com/physicianmba.                                                          =============== Get the FREE GUIDE to 10 Nonclinical Careers at nonclinicalphysicians.com/freeguide. Get a list of 70 nontraditional jobs at nonclinicalphysicians.com/70jobs.                                                                                                 =============== In this presentation, I share an updated list of seven fascinating and unexpected careers that physicians are quietly thriving in, far beyond traditional clinical roles. Drawing from past podcast interviews and my own experience as a CME surveyor, I highlight examples such as founding and leading professional associations, building online coaching and course businesses, part-time consulting, working as an independent disability insurance broker, serving as a chief medical officer for a Medicare administrative contractor, launching a health advocacy practice, and advising students as an academic consultant.  For each role, I explain what the work looks like, how the physicians got started, why the positions appealed to them, and what kind of income, flexibility, and purpose they've found in these paths. If you are feeling stuck or restless in clinical practice will come away with concrete, real-world examples of careers that still use medical training but offer very different ways to earn a living and help others.  You'll find links mentioned in the episode at nonclinicalphysicians.com/unexpected-careers/

Featuring a slide presentation and related discussion from Dr John V Heymach, including the following topics: Overview of the biology and treatment landscape of HER2-mutant non-small cell lung cancer (NSCLC) (0:00) Datasets evaluating trastuzumab deruxtecan for HER2-mutant NSCLC (5:03) Clinical data with zongertinib for HER2-mutant NSCLC (6:35) Emerging data with sevabertinib for HER2-mutant NSCLC (14:41) Other investigational strategies being evaluated for HER2-mutant NSCLC (19:10) Summary of the current and future treatment landscape of HER2-mutant NSCLC (21:52) CME information and select publications

Send us a textGroups that adopt AI thoughtfully will outpace those who don't—faster than most people realize.That's the bottom line. AI isn't some futuristic buzzword anymore. It's here, it's already changing how practices operate, and it's moving fast. Medical groups that learn how to integrate AI into their daily routines—clinically, operationally, administratively, financially—will be more efficient, more scalable, and frankly, more competitive than those who wait and see.If you're picturing robots walking around the office, let me stop you right there. We're not talking about futuristic sci-fi. We're talking about tools that write your notes for you, draft your emails, analyze your claim denials, and help you prepare for board meetings—all in a fraction of the time it used to take.Today, we're going to talk about practical, daily AI use for physicians and healthcare administrators. We're going to break it down into four key categories—areas where AI is already making a huge difference in real practices, and where it can start helping yours right away. Please Follow or Subscribe to get new episodes delivered to you as soon as they drop! Visit Jill's company, Health e Practices' website: https://healtheps.com/ Subscribe to our newsletter, Health e Connections: http://21978609.hs-sites.com/newletter-subscriber Want more formal learning? Check out Jill's newly released course: Physician's Edge: Mastering Business & Finance in Your Medical Practice. 32.5 hours of online, on-demand CME-accredited training tailored just for busy physicians. Find it here: https://healtheps.com/physicians-edge-mastering-business-finance-in-your-medical-practice/ Purchase your copy of Jill's book here: Physician Heal Thy Financial Self Join our Medical Money Matters Facebook Group here: https://www.facebook.com/groups/3834886643404507/ Original Musical Score by: Craig Addy at https://www.underthepiano.ca/ Visit Craig's website to book your Once in a Lifetime music experience Podcast coaching and development by: Jennifer Furlong, CEO, Communication Twenty-Four Seven https://www.communicationtwentyfourseven.com/

Jessica Inskip's Big 3 focuses on stocks she sees disappearing from investors' radars that will continue strong upside moves. She talks about CME Group's (CME) long-term play, IBM Corp.'s (IBM) acquisition of Confluent (CFLT) strengthening its enterprise A.I. positioning, and Walmart's (WMT) move to the Nasdaq defining its A.I. value. Rick Ducat takes investors through his key levels to watch in the stock charts. ======== Schwab Network ========Empowering every investor and trader, every market day.Options involve risks and are not suitable for all investors. Before trading, read the Options Disclosure Document. http://bit.ly/2v9tH6DSubscribe to the Market Minute newsletter - https://schwabnetwork.com/subscribeDownload the iOS app - https://apps.apple.com/us/app/schwab-network/id1460719185Download the Amazon Fire Tv App - https://www.amazon.com/TD-Ameritrade-Network/dp/B07KRD76C7Watch on Sling - https://watch.sling.com/1/asset/191928615bd8d47686f94682aefaa007/watchWatch on Vizio - https://www.vizio.com/en/watchfreeplus-exploreWatch on DistroTV - https://www.distro.tv/live/schwab-network/Follow us on X – https://twitter.com/schwabnetworkFollow us on Facebook – https://www.facebook.com/schwabnetworkFollow us on LinkedIn - https://www.linkedin.com/company/schwab-network/About Schwab Network - https://schwabnetwork.com/about

Silver is flashing every warning sign in the global financial system! 
In only the last 30 days we've seen:


For this episode hosts Drew, Tanner, and Andy are joined by performance scientist Jason Brooks to discuss the topic of Mental Interference. Do't forget we are the official podcast of the American College of Osteopathic Emergency Physicians. Visit acoep.org to learn more about this organization and how you can attend a future CME event!

Another State Street retail property sells at a big discount. Crain's reporter Rachel Herzog discusses the Loop retail corridor with host Amy Guth.Plus: Blue Cross parent CEO got a hefty raise in 2024 despite 54% income drop; CME data center outage caused by human error, Cyrus One says; Morningstar to revamp analysis of mutual funds; and Smith family of Northern Trust and ITW gives record-breaking donation to Rush cancer center. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Featuring perspectives from Prof Giuseppe Curigliano and Dr Priyanka Sharma, including the following topics: HER2-Positive Breast Cancer (0:00) Hormone Receptor-Positive Breast Cancer (18:16) Triple-Negative Breast Cancer (1:05:23) CME information and select publications

Prof Giuseppe Curigliano from the European Institute of Oncology in Milan, Italy, and Dr Priyanka Sharma from the University of Kansas Cancer Center in Westwood, Kansas, discuss the implications of clinical findings in breast cancer recently presented at the 2025 ESMO Annual Meeting. CME information and select publications here.

Dr. Kelly Casperson engages with Dr. Abraham Morgentaler and Dr. Marianne Brandon, the dynamic duo behind the Sex Doctors podcast. They discuss the evolution of testosterone therapy, the importance of advocating for women's health, and the complexities of male sexuality. The conversation emphasizes the need for open communication in relationships, the significance of mindfulness in enhancing sexual experiences, and the importance of screening for low testosterone in men. The doctors also share insights on navigating sexual boredom and mismatched desires, while providing resources for sexual health education. Takeaways The Sex Doctors Podcast aims to provide science-based insights into sexual health. Testosterone therapy has evolved significantly, challenging previous misconceptions. Medical dogmas can hinder patient care and need to be re-evaluated. Advocacy for women's health is crucial in the context of hormone therapy. Understanding male sexuality includes recognizing the reasons behind faking orgasms. Communication is key in addressing mismatched desires in relationships. Screening for low testosterone should be considered for men over 30. Mindfulness can enhance sexual experiences and intimacy. To my fellow clinicians: listen to this podcast on ⁠⁠⁠Pinnacle for FREE to earn CME credit⁠⁠⁠ Listen to my Tedx Talk: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Why we need adult sex ed⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Take my Adult Sex Ed Master Class:⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠My Website⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Interested in my sexual health and hormone clinic? ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Waitlist is open⁠⁠⁠⁠⁠⁠⁠⁠ Thanks to our sponsor ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Midi Women's Health⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠. Designed by midlife experts, delivered by experienced clinicians, covered by insurance.Midi is the first virtual care clinic made exclusively for women 40+. Evidence-based treatments. Personalized midlife care.⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.joinmidi.com⁠ Learn more about your ad choices. Visit podcastchoices.com/adchoices

Started out her medical career as an EKG tech and in EMS as an EMT for one of the first ambulance companies in the areaShe saw the disconnect between the provider that people wanted to become and who they became, and she didn't want that to be true for herselfShe became an attending in 1991 and now has close to 40 years in emergency medicineShe became a physician when it was predominantly a male fieldJulie talks about some of the things that have changed over timeWe need to have empathy for the people that come in for non-emergent complaints and realize that we have the honor in the ED to fill all the gaps in the wider medical systemWe talk about the increase in transparency with patients and the access they now have to their lab work, imaging and chart and this helps us increase trust with patientsJulie talks about a paramedic partner she really admired and how well she treated patients, and how there wasn't a lot of female role models for her in med schoolI talk about how I also had partners that really improved the trajectory I was on as a new EMTSeek first to understand is one of the 7 habits of highly effective people and this relates directly to taking care of patientsJulie talks about how it was to be a woman in medicine and how her voice got dismissed as well as the dynamics that are at play with patientsJulie talks about burnout and how labyrinth therapy helped her. How you need something that helps you look beyond yourself to have a moment of awe and gratitudeSupport the showEverything you hear today from myself and my guests is opinion only and doesn't represent any organizations or companies that any of us are affiliated with. The stories you hear have been modified to protect patient privacy and any resemblance to real individuals is coincidental. This is for educational and entertainment purposes only and should not be taken as medical advice nor used to diagnose any medical or healthcare conditions. This is not medical advice. If you have personal health concerns, please seek professional care. Full show notes can be found here: Episodes - Practical EMS - Content for EMTs, PAs, ParamedicsMost efficient online EKG course here: Practical EKG Interpretation - Practical EMS earn 4 CME and learn the fundamentals through advanced EKG interpretation in under 4 hours. If you want to work on your nutrition, increase your energy, improve your physical and mental health, I highly recommend 1st Phorm. Check them out here so they know I sent you. 1st Phorm | The Foundation of High Performance Nutrition

In a new Bloomberg interview, Gary Gensler emphasized that most digital tokens, lack fundamental value drivers such as cash flows, dividends, or intrinsic economic utility.~This Episode is sponsored by SALT~Borrow on SALT Now! ➜https://bit.ly/pbnsaltGuest: Shane Crockett, CBP - Head of Private Client Services00:00 Intro01:00 Gary Gensler returns03:15 Vanguard enters the space05:00 Gary Gensler: “Buy gold & Silver”07:00 How will interest rate affect Bitcoin lending?09:20 TVL vs volatility11:00 Could we see Tax Relief?12:30 Will new investors understand the SALT model?14:00 Long term vs Short term loans15:15 Will rate cuts create opportunites to open a loan?16:50 1/3/5 year loan duration options17:50 2026 Fed rate predictions18:00 Regulation 202619:30 Outro#Crypto #Bitcoin #Ethereum~Gensler Returns!

The Last Trade: Mark Yusko breaks down why the bitcoin cycle isn't dead, how futures and index flows “tame” BTC, why gold and oil remain the real benchmarks, and what this year's post-peak reset signals about an adversarial, institutional future.---

Featuring an interview with Dr Priyanka Sharma, including the following topics: Endocrine therapy for hormone receptor-positive, HER2-negative high-risk localized breast cancer (0:00) Johnston SR et al. monarchE: Primary overall survival (OS) results of adjuvant abemaciclib + endocrine therapy (ET) for HR+, HER2-, high-risk early breast cancer (EBC). ESMO 2025;Abstract LBA13. Durvalumab in combination with neoadjuvant chemotherapy for localized triple-negative breast cancer (TNBC) (3:25) Loibl S et al. Durvalumab in combination with neoadjuvant chemotherapy in early triple-negative breast cancer (TNBC) – Long-term analysis from the GeparNuevo trial. ESMO 2025;Abstract 292MO.  Efficacy and safety findings with TROP2-directed antibody-drug conjugates for metastatic TNBC (5:11) Cortés JC et al. Primary results from ASCENT-03: A randomized phase III study of sacituzumab govitecan (SG) vs chemotherapy (chemo) in patients (pts) with previously untreated advanced triple-negative breast cancer (TNBC) who are unable to receive PD-(L)1 inhibitors (PD-[L]1i). ESMO 2025;Abstract LBA20.  de Azambuja E et al. Patient-reported outcomes (PROs) with sacituzumab govitecan (SG) + pembrolizumab (pembro) vs chemotherapy (chemo) + pembro in patients (pts) with previously untreated PD-L1+ metastatic triple-negative breast cancer (mTNBC) in the phase III ASCENT-04/KEYNOTE-D19 study. ESMO 2025;Abstract LBA22.  Dent R et al. First-line (1L) datopotamab deruxtecan (Dato-DXd) vs chemotherapy in patients with locally recurrent inoperable or metastatic triple-negative breast cancer (mTNBC) for whom immunotherapy was not an option: Primary results from the randomised, phase III TROPION-Breast02 trial. ESMO 2025;Abstract LBA21.  CME information and select publications

Protect Your Retirement with a PHYSICAL Gold and/or Silver IRA https://www.sgtreportgold.com/ CALL( 877) 646-5347 - You Can Trust Noble Gold   With the CME "power outage" on Friday, it became abundantly clear to everyone that the silver squeeze is on and the bankster's paper games will be their undoing. As Silver surges again on Sunday evening to another new all-time high, what's next for the most manipulated and precious tangible asset on earth? Thanks for tuning in.   GOT PHYSICAL SILVER? Get some HERE: https://sdbullion.com/gold-silver-ira?utm_source=sgtreport https://old.bitchute.com/video/LOkfmVhLoti8/

Dr. Douglas Slakey is an internationally recognized transplant surgeon, author, educator, healthcare professional, and administrator. Doug is Professor and Chair of Health Systems Science at Belmont University and Leads the Belmont Collaborative for Health Systems Innovation. He founded Process Health Consulting, a healthcare consultancy focused on enhancing and optimizing operations and process flow, emphasizing complex system management strategies. He is an invited speaker at meetings around the world. He consults to help others improve patient care processes - improving safety, reliability, and patient-centric outcomes - always with compassion.Doug lives with his wife in beautiful Lake Tahoe, where they enjoy the outdoors, including hiking, skiing, and sailing. He has three children and five grandchildren.Link to claim CME credit: https://www.surveymonkey.com/r/3DXCFW3CME credit is available for up to 3 years after the stated release dateContact CEOD@bmhcc.org if you have any questions about claiming credit.

“This is a time to reimagine public health and public health/healthcare system integration,” says Dr. Deb Houry, the former chief medical officer for the US Centers for Disease Control and Prevention. In this thoughtful Raise the Line conversation, Dr. Houry reflects on unprecedented federal action in vaccine guidance and other issues since her noteworthy resignation from the CDC in August, and sees a more decentralized landscape emerging where states and localities play a larger role in providing public health recommendations. And while she acknowledges upsides to this shift, she's also concerned what the absence of a national consensus on health standards could mean. “Diseases don't recognize borders, and it's also important that people have equitable access to preventative services, vaccines, and other things,” she tells host Lindsey Smith. Tune in for Dr. Houry's seasoned perspective on this consequential moment in public health, and her encouraging message for learners and early career providers considering a career in the sector.Mentioned in this episode:DH Leadership & Strategy Solutions If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

Thank you to our sponsor, Uniswap! Class action lawsuits targeting crypto firms are on the rise. While observers often brush off the cases as opportunistic, they may be more of an existential threat than many think. In this episode of DEX in the City, hosts Jessi Brooks of Ribbit Capital, Katherine Kirkpatrick Bos of StarkWare, and Vy Le of Veda unpack what class action suits are and why they may be more of a threat to crypto than enforcement actions. Katherine breaks down the derivative case against Coinbase while Jessi explains why Binance has “bad facts” in the Hamas case. Meanwhile, Vy explains why the tussle over prediction markets like Kalshi by state gambling regulators could make it to the Supreme Court. Plus, China's crypto crackdown and the CME's outage. Hosts: Jessi Brooks, General Counsel at Ribbit Capital Katherine Kirkpatrick Bos, General Counsel at StarkWare TuongVy Le, General Counsel at Veda Links: Unchained: DEX in the City: Insider Trading and Crypto: What the Law Actually Says DEX in the City: Are Prediction Markets Gambling, and Who Should Regulate Them? Why Crypto Market Structure May Not Pass Until 2027: DEX in the City Mistrial Declared After ‘MEV Brothers' Accused of $25 Million Exploit Timestamps:

Monday's selloff rattled the entire market—Bitcoin, equities, commodities, you name it. But beneath the volatility, something more structural may be happening. In this week's Bits + Bips, Austin Campbell, Ram Ahluwalia, Chris Perkins, and B+B OG previous host Alex Kruger break down one of the most confusing macro weeks of the year. They debate why high-beta assets snapped, whether a rotation into quality is underway, why institutions seem unfazed even as retail stays skittish, and share initial thoughts on Vanguard finally allowing clients to buy crypto. The crew also unpacks Strategy's chaotic comments about selling BTC, the Clarity Act's political hurdles, the CME outage that exposed systemic fragility, and the never-ending debate over Tether—profitability, reserves, and what institutions actually want from a stablecoin issuer. Sponsors: Uniswap Mantle Hosts: Ram Ahluwalia, CFA, CEO and Founder of Lumida Austin Campbell, NYU Stern professor and founder and managing partner of Zero Knowledge Consulting Christopher Perkins, Managing Partner and President of CoinFund Guest: Alex Kruger, founder of Asgard   Timestamps:

Join us as we review recent articles and news featured in The DIGEST #70, including PSA screening, acetaminophen and autism, COVID19 vaccines and cancer, and aspirin and anticoagulation in coronary artery disease. Fill your brain hole with a delicious stack of hotcakes! Featuring Drs. Paul Williams (@PaulNWilliamz), Nora Taranto (@norataranto), Rahul Ganatra (@rbganatra), Laura Glick (@lauraglick) and Matt Watto (@doctorwatto). Claim free CME for this episode at curbsiders.vcuhealth.org! Episodes | Subscribe | Spotify | Swag! |Mailing List | Contact | CME! Credits Written and Hosted by: Nora Taranto MD; Rahul Ganatra MD MPH, Laura Glick MD, Paul Williams, MD, FACP, Adam Cifu MD, Matthew Watto MD, FACP Cover Art: Rahul Ganatra, MD MPH Reviewers: Rahul Ganatra MD MPH; Paul Williams, MD, FACP, Matthew Watto MD, FACP; Sai S Achi MD, MBA, FACP Technical Production: Pod Paste Showrunners: Matthew Watto MD, FACP; Paul Williams MD, FACP Show Segments Intro, disclaimer Prostate Cancer Screening Acetaminophen and Autism COVID19 vaccines and cancer risk Aspirin and anticoagulation in coronary artery disease Outro Sponsor: Aura Frames For a limited time, save on the perfect gift by visiting AuraFrames.com to get $35 off Aura's best-selling Carver Mat frames by using promo code CURB at checkout. Sponsor: DoxGPT by Doximity Visit doxgpt.com  and see how it can simplify your clinical workflow, from patient care to paperwork.  Sponsor: Continuing Education Company Use promo code Curb30 to get 30% off all online courses and webcasts—just for Curbsiders Listeners. Visit CMEmeeting.org/curbsiders to learn more. Sponsor: Freed Use code: CURB50 to get $50 off your first month when you subscribe!